Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Sales (2016 - 2025)

Historic Return on Sales for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to 0.07%.

  • Marimed's Return on Sales fell 500.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.08% for FY2024, which is 300.0% up from last year.
  • According to the latest figures from Q3 2025, Marimed's Return on Sales is 0.07%, which was down 500.0% from 0.03% recorded in Q2 2025.
  • Marimed's 5-year Return on Sales high stood at 0.23% for Q2 2021, and its period low was 0.26% during Q4 2023.
  • For the 5-year period, Marimed's Return on Sales averaged around 0.02%, with its median value being 0.03% (2023).
  • The largest annual percentage gain for Marimed's Return on Sales in the last 5 years was 4900bps (2021), contrasted with its biggest fall of -5100bps (2021).
  • Quarter analysis of 5 years shows Marimed's Return on Sales stood at 0.21% in 2021, then soared by 164bps to 0.13% in 2022, then tumbled by -297bps to 0.26% in 2023, then rose by 22bps to 0.2% in 2024, then soared by 65bps to 0.07% in 2025.
  • Its last three reported values are 0.07% in Q3 2025, 0.03% for Q2 2025, and 0.14% during Q1 2025.